Nkarta promotes David Shook to Chief Medical Officer

Jan. 10, 2023 2:17 AM ETNkarta, Inc. (NKTX)By: Meghavi Singh, SA News Editor
  • Nkarta (NASDAQ:NKTX) notifies the promotion of David Shook, to the role of CMO.
  • Shook has expertise in cell therapy development and continues to lead Nkarta's global clinical development and regulatory operations.
  • Shook joined Nkarta in 2020 and was appointed as VP, clinical development in 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.